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Abstract
Characterization of the human antibody (Ab) repertoire in mouse models of the human immune
system is essential to establish their relevance in translational studies. Single human B-cells were
sorted from bone marrow and periphery of humanized NOD/SCID γcnull mice at 8–10 months
post-engraftment with human cord blood-derived CD34+ stem cells. Human immunoglobulin
variable heavy (VH) and kappa (Vκ) genes were amplified, cognate VH-Vκ gene-pairs assembled
as single-chain variable fragment-Fc antibodies (scFvFcs) and functional studies performed.
Although overall distribution of VH genes approximated the normal human Ab repertoire, analysis
of the VH-third complementarity determining regions (H-CDR3) in the mature B-cell subset
demonstrated an increase in length and positive charges suggesting autoimmune characteristics.
Additionally, >70% of Vκ sequences utilized Vκ4-1, a germline gene associated with
autoimmunity. The mature B-cell subset-derived scFvFcs displayed the highest frequency of
autoreactivity and polyspecificity, suggesting defects in checkpoint control mechanisms.
Furthermore, these scFvFcs demonstrated binding to recombinant HIV envelope corroborating
previous observations of poly/autoreactivity in anti-HIVgp140 antibodies. These data lend support
to the hypothesis that anti-HIV BnAbs may be derived from auto/polyspecific Abs that escaped
immune elimination and that the hNSG mouse could provide a new experimental platform for
studying the origin of anti-HIV neutralizing Ab responses.
Keywords
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Introduction
Advancement in high-throughput screening techniques has led to the recent discovery of
several highly potent broadly neutralizing antibodies (BnAbs) against HIV1–4 and Influenza
A5 recovered from peripheral blood (PB) derived B-cells of infected individuals; however,
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tthe occurrence of these BnAbs is extremely rare. This has spurred a renewed interest in
‘rational vaccine design’ where it may be feasible to analyze the patient’s antibodyome in
order to obtain insight into the ontogeny of the BnAbs.6 This information may then be used
to design candidate vaccines in order to improve BnAb responses.4
Given the cost and ethical constraints of using human subjects for investigative vaccine
studies, there is a growing need for a predictive and surrogate system to study human Ab
evolution at the single-cell level. “Humanized” mouse models are increasingly being used to
study human immunity, developmental and disease processes.7, 8 Newer mouse models
deficient in the expression of the interleukin-2 receptor (IL2R) γ-chain (γcnull), including
NOD/SCID γcnull (NSG), BALB/c-Rag2−/−γcnull and H2d- Rag2−/− γcnull mice support the
development of a multi-lineage human hemato-lymphoid system following transplantation
with fetal or adult hematopoietic stem cells (HSC). Additionally, these engrafted γcnull mice
exhibit normal life spans, unlike previous models, thus enabling long-term studies.9 In spite
of these favorable advances, the adaptive Ab responses of these animals are weak with
barely detectable secondary responses including class switching and affinity maturation.7
Growth factor supplementation with human BLyS10 and T cell-cytokines11 in order to
support growth and differentiation of the transplanted cells has resulted in only marginal
improvement. Treatment of these mice with human cytokines and other costimulatory/
growth factors delivered by a variety of techniques are being actively investigated to further
improve human immune system development.12
Clonal diversity and immune tolerance are two major cornerstones of an effective Ab
response that must also be considered in the evaluation of these mice as a relevant platform
system to study human Ab responses. Several studies have evaluated immune repertoire
complexity in hNSG mice by TCR CDR3 spectratyping,9 BCR H-CDR3 immunoscope
analysis13 and multiplex PCR of V-J rearrangements of TCRβ and H-CDR314 and have
concluded that both repertoires show levels of diversity comparable to those of humans. In
addition, there have been two reports that analyzed the diversity of the IG repertoire with a
focus on only the VH4 family in NOD/SCID and NOD/SCID/β2mnull mice.15, 16 However, a
systematic study in which the diversity of the human B-cell repertoire is analyzed via
genetic and functional analysis of the variable (V), diversity (D) and joining (J) gene
segments of the IG heavy and light chain genes has not been performed in hNSG mice.
Analysis of immune tolerance in hNSG mice by the evaluation of the physiologic
checkpoint control mechanisms that are normally operative during B-cell development17, 18
has also not been reported (see Mouquet et al17 for schema).
In the present study, analysis of VH and Vκ gene arrangements in hNSG-derived single
human B-cells sorted at different developmental stages was performed. Nucleotide and
amino acid sequence analysis of the heavy chain genes indicated the presence of a diverse
antibody repertoire; however, characterization of H-CDR3 regions and a specific restriction
in the Vκ repertoire suggested an autoreactive potential. This was further confirmed by
functional studies where scFvFcs cloned from single B-cells were found to exhibit binding
to self-antigens. Intriguingly, many autoreactive clones also displayed affinity for HIV-1
envelope protein gp140 (HIV-1gp140). These data lend support to the contemporary
hypothesis that anti-HIV BnAbs may be derived from auto/polyspecific Abs that escaped
immune elimination.19, 20 Thus, the defects in immune tolerance in these hNSG mice may
provide a unique model to study the development of anti-HIV BnAbs where ancestral
origins of antibodies can be determined and the existing HIV-reactive Ab clones can be
modulated via experimental infection or immunization.
Chang et al. Page 2
Genes Immun. Author manuscript; available in PMC 2013 January 01.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tResults
B-cell development in long-term engrafted hNSG mice
Significant numbers (>10% of total lymphocytes) of human CD45+ (hCD45+) cells could be
detected in the PB of hNSG mice between 1–2 months post HSC injection; however, total
human CD3+ T cells remained low (<5% of total hCD45+ cells) during that time. At 6
months post HSC injection, the hCD45+ frequency in the PB of the hNSG mice was 43.87 ±
10.11% (n = 8) of total lymphocytes, of which 41.49 ± 22.75% stained for hCD3 (T cells)
and 53.28% ± 21.5% for hCD19 (B-cells). Of the total CD19+ human B-cells, 53.64 ±
12.69% expressed the CD5 surface antigen, which was higher than the reported level of
circulating CD19+CD5+ cells (~15%) found in humans.21 Profiles of the different CD19+ B-
cell subpopulations in the hNSG mice at >6 months post HSC transplantation at the time of
single B-cell sorting are shown in Figure 1. B-cells at all major stages of the developmental
pathway (early immature, immature, new emigrant and mature naïve) were detected, but
CD27+ B-cells, associated with a memory phenotype22 were notably absent. Overall, the
data demonstrate that the human B-cell developmental pathway is recapitulated in the hNSG
mice; however the memory B-cell compartment is not or only sparsely populated.
Analysis of human VH sequences
Table 1 summarizes the total data set analyzed in the present study. Single B-cells from
different B-cell subpopulations were sorted, and IG gene sequences were obtained as
described in Methods. In total, 257 and 264 sequences unique for human immunoglobulin
(IG) heavy and light chains, respectively, were obtained and further analyzed. Intriguingly,
in the first round PCR reactions to amplify kappa (Vκ) and lambda (Vλ) light chain genes,
only those sequences that corresponded to kappa light chain gene segments were recovered.
PCR mediated primer bias was ruled out by using the same primer mix to amplifyheavy and
lightchain genes from single-sorted mature B-cells from a normal human donor. From a total
of 192 single-sorted human PB B-cells, 137 VH, 44 Vκ and 33 Vλ unique and productive
gene segments could be amplified (Supplementary Figure 1). The reason(s) for this observed
exclusivity of the Vκ genes is currently under investigation and may include factors, such as
Vλ transcript instability, greater Vλ variability and Vκ gene rearrangement bias in the hNSG
mice.
Individual IG sequences were aligned with the International Immunogenetics Information
System (IMGT) database, and the overall germline usage was determined. Human VH gene
segments are divided into 7 families, named VH1–7 with 51 known functional genes and
>40% of the genes representing the VH3 family (IMGT). VH sequences from all except VH2
and VH6 families were represented in the hNSG mice, and the sequence usage from
different VH gene families across the B-cell subpopulations is shown in Figure 2, upper
panel. In comparison to the human VH repertoire found in normal adults,23, 24 gene
segments corresponding to the VH3 family were most frequently utilized followed by VH4
in most of the B-cell subpopulations. An exception was observed in new emigrant B-cells
where the VH3 usage (17.4%) was marginally lower than that of VH4 (22.5%). Additionally,
VH7 gene segments were detected at a frequency higher than normally found (~2% in the
human VH repertoire, IMGT), particularly in the early immature stage of B-cell
development where it was ~12% of the total VH sequences (Supplementary Table 1). No
other significant differences were found in the distribution of the VH gene families across
the different B-cell subsets. These observations suggest that the VH repertoire in the hNSG
mouse is quite diverse with 36 out of 51 known functional genes found at least once in the
various subpopulations (Supplementary Table 1). Among individual gene segments, VH4–
34, VH3–30 and VH1–2 were utilized most often. VH4–34 was most frequently observed in
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tthe repertoire of all the B-cell subsets, except for the immature subpopulation where VH3–
30 had the highest occurrence.
Analysis of VH rearrangement and H-CDR3 composition
The complexity of the IG repertoire is enhanced by gene rearrangement of VH with DH and
JH segments and Vκ/λ with Jκ/λ segment for the light chain. Therefore, the utilization of the
DH and JH gene segments across the different B-cell subpopulations was analyzed next
(Figure 2, middle and lower panels, respectively). The DH genes are classified into 7
families, DH1–DH7. As reported for humans,25 the usage of the DH3 family in the hNSG
mice was significantly more frequent than the other families (p<0.005, Exact Fisher-
Freeman-Halton Test). An increase in the usage of DH1 and DH2 segments along the CD5−
B-cell developmental pathway was observed (early immature<immature<new
emigrant<mature). There were differences between the mature CD5− and CD5+ B-cells in
terms of DH gene segment usage, particularly with regards to the utilization of DH2 (lower
in CD5+ B-cells), DH3 (higher in CD5+ B-cells) and DH5 gene segments (absent in CD5+ B-
cells). Rearrangement of DH gene segments may occur either through inversion or deletion
processes which determines the DH reading frame utilized. An analysis of the usage of the
DH reading frame (RF) indicated a significantly higher utilization of RF2, found on an
average of 51% of all the sequences across all B-cell subsets in the hNSG mice (p<0.005,
Fisher’s Exact Test, data not shown). This draws a parallel to that observed for normal
human DH gene rearrangements where deletion was found to be the favored process along
with a lower frequency of the use of RF3.25 The distribution of JH genes clearly showed a
higher bias for JH4 usage (p<0.005, Fishers’ Exact Test). No significant difference was
observed between the mature B-cell subsets (p>0.005, Fisher’s Exact Test). However,
distribution of JH6 usage compared to all other JH segments (except JH3) was found to be
significantly higher in the mature B-cell subsets (CD5+ and CD5−) compared to the BM-
derived B-cells (early immature and immature B-cells) (p<0.005, Fisher’s Exact Test).
The H-CDR3 region is considered to be an important determinant that imparts antibody
specificity as well as affinity. The overall composition of H-CDR3 regions in terms of
length, positive charge content, N-nucleotide insertions and exonuclease activity was
analyzed (Figure 3). Extremely long (>20 amino acids) H-CDR3 regions were more frequent
in the CD5− mature B-cell subset, which may be explained by the higher utilization of the
JH6 segment by this group of cells that results in longer CDR3.25 Additionally, this same B-
cell subset carried more cells with 2+ and 3+ positively charged residues in the H-CDR3
compared to the CD5+ B subset. While increases in length and positive charges in the H-
CDR3 region are expected in the IG repertoire from BM-derived immature B-cell
populations, these are less frequently observed when the B-cells mature and migrate to the
periphery. Thus, the mature B-cell subset in the hNSG mice with longer and increased
positive charges in their H-CDR3 regions is a major and previously unrecognized difference
from their counterpart in normal humans. No significant difference in N-insertions and JH
exonuclease activity between the B-cell subpopulations was observed (p<0.005, Fishers’
Exact Test) (Figure 3b). A bias in Tyrosine (Y) and Glycine (G) composition in the H-
CDR3 regions (40–50% of total residues) that is observed in normal humans 26 was
recapitulated in the hNSG mice (Figure 3a).
Presence of hypermutated VH sequences
Hypermutation in the VH sequences was analyzed by comparing against the closest germline
sequences, and the B-cell subpopulations were classified as those with identical or highly
homologous (99–100% homology), moderately mutated (94–99%) and highly mutated
(≤94%) sequences as described earlier for analysis of human IG VH repertoire24 (Table 2).
Accumulation of hypermutated VH sequences (≤99%) was significantly lower in the mature
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tB-cell subsets in the periphery compared to the earlier stages in development in the bone
marrow (p<0.005, Fishers’ Exact Test). In contrast to an earlier report,24 where IgM+CD5+
human B cells were found to accumulate significantly higher number of mutations compared
to the IgM+CD5− B cells, we did not observe a significant difference between the CD5− and
CD5+ mature B-cell subsets (p<0.005, Fishers’ Exact Test). Moreover, the VH repertoire in
the peripheral B cells were notably devoid of highly mutated sequences, e.g., displaying
<94% homology to germline sequences. Analysis of the mutations in the Framework
Regions (FR) and H-CDR3 both at the nucleotide and amino acid residue levels revealed the
occurrence of both silent as well as replacement mutations (Table 2).
Potential VH replacement in hNSG mice
The cryptic recombination signal sequence (cRSS, TACTGTG)27 at the 3′-end of
rearranged VH genes allowed the detection of potential VH replacement products. The cRSS
is the binding motif for the recombinase activating gene (RAG) family of enzymes that
mediate VH replacement, a process in which a secondary arrangement of an upstream VH
sequence occurs in an already formed VH-DH-JH gene.27 Remarkably, 13 potential VH
replacements in the 257 VH sequences were detected (Table 3). This secondary
rearrangement process was not confined within the early stages of B-cell development and
did not only involve VH4 genes as reported earlier. 28, 29 In order to confirm the validity of
the sequences scored as the products of VH replacement, a similar scan was performed on
the DH-JH junction of the VH sequences. One major criteria of such replacement products, as
shown in Table 3, is that they often encode highly charged amino acid residues (R/D/E).30
No such sequences were identified in the DH-JH region of the VH genes.
Analysis of human Vκ sequences and cognate VH-Vκ pairs
Figure 4a presents an analysis of the Vκ sequences recovered from the different human B-
cell subsets obtained in the hNSG mice. The human κ locus contains 44 functional gene
segments divided into 5 gene families: Vκ1–Vκ5 (IMGT). Only a single member is known
for each of the Vκ4 and Vκ 5 families, Vκ 4-1 and Vκ 5-2 respectively (IMGT). At least 24
unique Vκ gene segments, representing 4 out of 5 Vκ gene families in the B-cell
subpopulations, were detected with a distinct bias towards the utilization of Vκ 4-1
(Supplementary Table 2). Notably, the Vκ 4-1 gene segment is located most proximally in
the human κ locus on chromosome 2; however, the significance of this location with regards
to the overutilization of this gene in the hNSG mice is presently unclear. Vκ5 family genes
remained undetected in the hNSG mice, which may be attributed to the limited sample size.
An analysis of the Jκ sequences demonstrated the utilization of all known Jκ segments in the
human IG repertoire (Jκ1–Jκ5) with an overrepresentation of the Jκ4 gene segments across
all B-cell subpopulations (Figure 4a).
VH-Vκ pairs derived from single B-cells were interrogated for the frequency of pairing of
individual heavy and light chains across different cell subsets (Figure 4b), and a complete
list of the pairings is shown in Supplementary Figure 2. Given that each VH-Vκ pair
represents a unique Ab, the profile of heavy and light chain pairing across the different B-
cell subsets can provide information on antibody evolution, clonality, editing and other
physiological processes that shape the IG repertoire. Interestingly, as represented in Figure
4b, a significant decrease in VH -pairing with Vκ 4-1 in mature B-cells (CD5+ and CD5−)
was found when compared to BM-derived B-cell subsets (p<0.005, Fishers’ Exact Test).
Given that the usage of Vκ 4-1 has been associated with autoreactivity and anti-DNA auto-
antibodies,31 the decreasing frequency of Vκ4-1 usage with increasing B-cell maturation
suggests that checkpoint control mechanism(s), which are associated with peripheral
tolerance, are at least partially intact.
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Total human IgM and IgG concentrations in hNSG mouse serum ranged between 15–50 and
20–90 μg/ml, respectively, which were ~10–50 and ~100–200 fold lower than normal
human serum IgM and IgG levels. By comparison, in newborns the antibody levels
approximate that found in adults, albeit they increase with time, plateauing at ~1 year for
IgM and ~5–6 years for IgG. 32 It has also shown that in human bone marrow transplants,
serum IG levels return within normal levels by day 90 post transplant.33
The physiological presence of auto/polyreactive antibodies was next tested by analyzing the
binding of serum IgM and IgG antibodies by ELISA to a panel of antigens, including
cardiolipin, insulin, ssDNA, dsDNA and LPS, and the overall reactivity was compared to
normal human sera. As shown in Figure 5, the hNSG mice sera showed significantly higher
binding levels over that of normal human sera to all antigens tested, and this auto/
polyreactivity was almost entirely restricted to the IgM fraction (p<0.005, Mann Whitney
Test). An increased level of binding to LPS by both normal human IgG and IgM may be
attributed to ‘natural antibodies’ present in the serum.34
To investigate this auto/polyreactivity in more detail, additional studies were performed on
recombinant Abs recovered from single B-cells. As shown in Table 1, 176/219 cognate VH-
Vκ pairings representing all different human B-cell subsets were successfully assembled into
scFvs (80% efficiency), expressed as scFvFcs and purified for functional studies. To
determine the autoreactivity of these Abs, HEp-2 (human epidermoid cancer cell) ELISA
which is a standard clinical assay for detection of anti-nuclear antibodies (ANAs) was
performed. As shown in Figure 6a, autoreactive ANAs were detected in all B-cell subsets.
Circa 50% of the scFvFcs from all B-cell subsets were scored as autoreactive, with the
exception of the CD5− mature B-cell subset where autoreactivity was observed in a
significantly higher percentage of the Abs (80.7%) compared to the other B-cell subsets
(p<0.005, Mann Whitney Test). The reactivity of all 176 scFvFcs against each antigen is
shown in Figure 6b. There was a significant increase in the median reactivity levels of
antigen binding in the mature B-cell subsets when compared to that observed for the B-cells
at earlier stages in development (p<0.005, Mann Whitney Test). No significant difference
was observed between the CD5+ and CD5− mature B-cell subsets. All polyreactive Abs also
scored positive in the ANA assay. Additionally, scFvFcs demonstrating high level reactivity
to one antigen also bound strongly to other antigens. Thus, the results of both the serologic
and single B-cell derived binding studies provide evidence for the retention of a substantial
pool of auto/polyreactive B-cell clones centrally in the bone marrow and particularly in the
periphery, suggesting that the first two checkpoint control steps (between early immature to
immature and new emigrant to mature) involved in clearance of autoreactive clones are
impaired.17 ELISA binding studies using a comparable mouse cell line to test scFvFc
autoreactivity to mouse ANA antigens, may provide additional information on autoreactivity
given the development of these human B-cells in the murine host.
A total of 22 scFvFcs were scored based on their absolute MSD values (>3 fold background
as obtained from reactivity of buffer alone to antigen coated wells) as low, medium, and
highly polyreactive based on the relative reactivity of 4E10 to the same antigens (<20%, ≥
20–60%, and ≥60% of 4E10 scFvFc reactivity, respectively). Of these 22, 2 were from the
early immature B-cell subset, 1 from immature, 2 from new emigrant, 13 from the CD5−
mature B-cells and 4 from CD5+ B-cells. To identify any common features between the 22
polyreactive scFvFcs in terms of sequence composition, the respective VH and Vκ families
and H-CDR3 length and positive charge composition were compared (Supplementary Table
3); however, except the fact that the majority of the light chain sequences corresponded to
Vκ 4-1, no other obvious similarities was observed.
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Previous studies have reported that several anti-HIV-1 envelope directed BnAbs including
2F5 and 4E10 show promiscuous binding to multiple auto-antigens, which raises the
hypothesis that their rare appearance may be due to escape from immune tolerance.35, 36 A
more recent study demonstrated that 75% of all anti-HIV antibodies isolated from infected
individuals showed polyreactivity against ssDNA, dsDNA, cardiolipin, LPS and keyhole
limpet hemocyanin by ELISA.19 Given the auto/polyreactive binding profiles above, both
serum and the hNSG-derived scFvFcs were tested for reactivity to HIV-1 envelope. As
shown in Figure 7a, sera samples from hNSG mice displayed significantly higher reactivity
to HIV gp140 compared to human serum controls with most of the reactivity restricted to the
IgM fraction. Given that the IgG content in normal human serum is 100–200 folds higher
than that in hNSG sera, the apparently higher reactivity of normal human IgG is most likely
a concentration effect rather than antigen specificity. Furthermore, in a similar pattern to that
described earlier, the scFvFcs derived from the mature B-cells displayed significantly higher
binding to HIV-1 envelope protein compared to the scFvFcs derived from B-cells earlier in
developmental pathway (Figure 7b).
Kinetic analysis of two random scFvFcs displaying high (N1M10-1, isolated from CD5+ B-
cell subset) and medium reactivity (NM10-1, isolated from CD5− mature B-cells) for
binding to HIVgp140 trimer protein was performed using Biolayer Interferometry, and kon,
koff and KD values of the scFvFcs (b12 and 4E10 IgG used as positive controls) were
measured. The sensorgrams of each antibody-binding (which were immobilized on Protein
A sensors) to a series of different concentrations of HIV envelope protein in solution are
shown in Figure 7c. The association rates (kon) of the scFvFcs were comparable to that of
b12 and 4E10 [kon(1/Ms) values were 4.69 x 106 and 5.54 x 105 for N1M10-1 and NM10-1,
respectively, whereas it was 2.89 x 105 and 2.55 x 105 for b12 and 4E10 respectively)];
however, the scFvFcs dissociated from the target protein at a faster rate [koff (1/s) values
were 2.68 x 10−2 and 2.40 x 10−2 for N1M10-1 and NM10-1, respectively, whereas it was
4.19 x 10−5 and 1.42 x 10−4 for b12 and 4E10 respectively)]. Intriguingly, the equilibrium
dissociation constant (KD, in M) values of the scFvFcs obtained from naïve hNSG mice
closely approximated those of the HIV BnAbs, with KD values of 5.72 x 10−9 for both
N1M10-1 and NM10-1, and 1.45 x 10−10 and 5.56 x 10−10 for b12 and 4E10 respectively.
Although these Abs displayed substantial affinity to HIV envelope protein, they did not
show neutralizing activity to HIV-1 or compete with target binding of b12 or 4E10 (data not
shown) most likely due to their fast dissociation rates.
Auto/polyreactivity is still present in “humanized” BLT and GTL mice
To address the question of whether T cells affect the antibody repertoire as suggested
earlier,37 similar studies were performed with humanized BLT and GTL mice. Although
both the BLT38 as well as the GTL mice display a rapid development of human T cells
(human T:B cell levels in these mice approximate that found in normal adults) as a result of
co-engraftment of human thymic tissue in addition to CD34+ stem cells, preimmune serum
antibody levels of human IgM and IgG were not improved over that observed for the hNSG
mice. Following similar methods as described for the hNSG mice, single human B-cell
sorting of mature splenic B-cells (CD19+IgM+CD10−), Ab gene recovery and scFvFc
assembly were performed from a single BLT and GTL mice 16–20 weeks post tissue
transplantation. A total of 59 and 37 scFvFcs was assembled from mature human B-cells
isolated from the spleen of a BLT and GTL mouse, respectively. The gene usage profile for
heavy and light chain variable regions was comparable to that observed for the hNSG mice,
including the lack of somatic hypermutations in the VH sequences, sole recovery of Vκ
genes and an overutilization of Vκ4-1 (data not shown). A majority of the scFvFcs, ~75%
and ~78%, from the BLT and GTL mice respectively, also displayed auto- and
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tpolyreactivity as shown in Supplementary Figure 3. These results suggest that the
polyreactive IG repertoire is not exclusive to the hNSG model, and it is likely that other
“humanized” mouse models may share common deficiencies in peripheral tolerance
mechanisms.
Discussion
In this study, we performed an in depth analyses and characterization of the human antibody
repertoire in the humanized NSG mouse model. The hNSG mice supported the development
of a multilineage human hematopoietic system following transplantation with human
hematopoietic stem cells, and at 8–10 months post-transplantation, phenotypic
characterization indicated a normal B-cell developmental pathway with immature B-cells
residing predominantly in the bone marrow and the mature cells in the periphery. However,
several deviations were noted, some of which have been reported earlier, e.g., slow
development of human T cells9 and a higher than normal frequency of CD19+CD5+ B-cells
in the periphery.38, 39 Additionally, the current work provides evidence for the first time that
the human antibody repertoire that develops in the hNSG and other humanized mouse
models is largely auto- and polyreactive.
The human VH diversity in the hNSG mice appears to closely approximate to that of the
normal adult IG repertoire in terms of germline gene usage, but with an unexpectedly high
level of positively charged, long H-CDR3s in the mature CD5- population that displayed
increased auto/polyreactivity. There was also an abnormal high contribution to the
rearranged VH gene pool from the CD5+ B cells in the periphery (Figure 6A). It has been
previously shown that increased numbers of CD5+ B cells are found in the cord blood which
display auto/polyreactivity.40, 41 It is doubtful that the source of human stem cells induces
the development of CD5+ B cells in the humanized mice, since CD5+ B cells have also been
shown to develop in the hNSG mice when engrafted with stem cells derived from the adult
bone marrow or mobilized peripheral blood.39 In early life, a restricted VH repertoire
resulting from limited IG diversity has been observed which coincides with the observed
autoreactivity in the B cell clones isolated from fetal liver and cord blood.42, 43 In addition,
in fetal liver B cells there is skewing in the distribution of VH genes which are
chromosomally located closer to the DH-JH-CH locus. 44 Recently, next-generation
sequencing (NGS) of expressed antibody repertoires from human cord blood cells have
shown comparable frequencies of VH germline gene usage to those present in adult IgM
repertoire except for the high frequency of VH1–2 germline gene that was preferentially
expressed in the cord blood cells. As expected lower degree of somatic mutation in the CDR
and framework regions was observed in the cord blood cells.45 While our genetic analyses
show both similarities and differences compared to the different VH repertoires discussed
above, the auto/polyreactivity of the hNSG antibodies set their functional maturity at an
early stage.
The observations of a large pool of auto/polyreactive antibodies in the humanized mice
made in this study raise two inter-related questions; 1, why are the autoreactive B cell clones
retained in the periphery; and 2, are the auto/polyreactive antibodies in the humanized mice
akin to normal circulating ‘natural antibodies’ found in both men and mice.46 During normal
course of B-cell development, a majority of the self-reactive B-cell clones are eliminated by
checkpoint control mechanisms as characterized by Wardemann and colleagues.18 A
‘central’ checkpoint occurs in the BM during the development of immature B-cells from the
previous early immature stage and a ‘peripheral’ checkpoint between the new emigrant and
the mature phase of B-cell development. A third checkpoint has also been predicted that
eliminates residual autoantibodies from the IgM+ memory B-cells.47 These checkpoint
controls result in a significant reduction in H-CDR3 length and positive charge content from
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corresponding early immature and new emigrant B-cell stages. Our data support that the
peripheral checkpoint control mechanism in the hNSG mice may be impaired given the
significant increase in the number of mature B-cells carrying long and highly charged H-
CDR3 regions. The factors regulating these checkpoint control steps have not been
identified, and human B-cell ontogeny in a xenogeneic environment adds to the complexity.
Autoreactive B-cells are thought to be selected for elimination by their reactivity to self-
antigens by deletion and receptor editing. In the hNSG BM, human B-cell development
conceivably occurs by selection against both donor (human) as well as self (mouse) antigens
and additionally, the distribution of these antigens may be varied in different compartments
(e.g., bone marrow vs. periphery). This may result in improperly ‘educated’ human B-cells,
particularly in the periphery where self-antigens predominate and the peripheral checkpoint
control mechanism(s), designed to eliminate autoreactive clones, could be more impaired.
Despite the apparent autoreactivity in the periphery, these mice did not display any apparent
signs of autoimmunity, i.e. symptoms of graft-versus-host disease (GvHD), e.g., anorexia,
wasting, alopecia, etc.
We verified to a great extent, that the predominance of Vκ sequences, particularly Vκ 4-1
gene segment, as the exclusive light chain partner in all assembled antibodies was not a PCR
induced bias. The fact that cloned and serum antibodies alike displayed autoreactivity and
polyspecific responses to multiple antigens provide a strong correlation with Vκ 4-1
prevalence. These results also illustrate an apparent defect or insufficiency in one of the
major mechanisms of silencing self-reactive B-cells; light chain receptor editing which is
mostly mediated by Vλ genes.48 Polyreactive antibodies have also been detected in the IgG+
memory B-cell pools from normal human subjects, and these have been described as a by-
product of extensive somatic hypermutation occurring during antigen-induced B-cell
differentiation.47 This observation is, however, irrelevant to the current study, as neither a
memory phenotype nor a high level of hypermutation was observed in all the B-cell clones
studied.
Natural antibodies secreted by B cells are predominantly of the IgM subclass, but are also
represented by IgG and IgA isotypes. These antibodies have been characterized extensively
in mice49 and are present during early human life.50 A distinct B cell subset, called B-1
cells, characterized by surface expression of the CD5 marker has been found to be the major
producer of natural antibodies in mice. In addition to displaying low affinity interactions
with self-antigens, these antibodies have also been found to play a major role in early
protective responses against pathogens.34 Further studies remain to be performed to
understand the nature of the auto/polyreactive human antibodies that develop in the hNSG
mice under pathogen-free conditions and whether the CD5+ human B cells represent the
murine equivalent.
A number of anti-HIV envelope BnAbs have shown characteristics of auto/polyreactive
antibodies and thus, it has been proposed that the rare emergence of such antibodies in the
vaccinated or infected host may be due to physiologic tolerance mechanisms that are
operative during B cell development.51 Recently, it was also shown that HIV envelope
reactive antibodies isolated from ‘elite controllers’ of infection were polyreactive and that
heteroligation to gp120 and self-antigen can increase the apparent affinity of the antibodies
for HIV.19 The preponderance of peripheral auto/polyreactive antibodies in naïve and germ-
free hNSG mice that also show binding to HIV envelope proteins may provide a model in
which the generation and origins of protective antibody responses against HIV can be
investigated. Indeed, since many of these antibodies already display binding to the HIV
envelope, their potency could be further enhanced by experimental infection or
immunization. Therefore, the hNSG and other similar mouse models may provide a novel
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texperimental system in which the breakdown in physiologic tolerance mechanisms can be
exploited to further investigate the role that auto/polyreactivity may play in the development
and evolution of HIV BnAbs. This knowledge will be of critical importance to current and
future HIV/AIDS vaccine efforts.
Materials and methods
Construction of humanized mice
Male NSG mice, 6 wk of age (Jackson Laboratory, Bar Harbor, ME), were housed under
BSL-2 conditions at the Animal Research Facility (ARF), Dana-Farber Cancer Institute
(DFCI, Boston, MA). Mice received autoclaved food and Baytril (fluoroquinolone) -treated
water. CD34+ HSC were isolated from human umbilical cord blood, obtained from Brigham
and Women’s Hospital (BWH, Boston, MA), using immunomagnetic column purification
techniques (MiniMACS) per the manufacturer’s protocol (Miltentyi, Auburn, CA). At ~8
wk of age, mice were sublethally irradiated with 325 cGy (Gammacell-40, Best
Theratronics, Ottawa, Canada) and then injected with 2.5 × 105 HSC resuspended in 200 μl
of phosphate buffered saline (PBS) via the tail vein. NOD/SCID-thy/liv (also called BLT)
and NSG-thy/liv (GTL) mice were also constructed as previously described.38 Briefly, 6–8
week old NOD/SCID or NSG female mice were ‘humanized’ following implantation of
human fetal liver and thymus tissues under the kidney capsule along with an intravenous
delivery of fetal liver-derived autologous CD34+ stem cells. All fetal tissues (17–20 weeks
of gestational age) were obtained from Advanced Bioscience Resources, Alameda, CA.
Tissues were also screened for the presence of HIV-1 and 2 and Hepatitis B virus and
determined to be negative.
Mice were bled monthly via the mandibular route, and engraftment levels were determined
by flow cytometry analysis of human CD45+ cells in the peripheral blood. All studies
involving human tissues were approved by the Institutional Review Boards at both DFCI
and BWH.
Flow cytometry
Analysis of human immune reconstitution following CD34+ HSC delivery was performed
by flow cytometry (supplemental methods). Cell isolation techniques and criteria for single
cell sorting from different human B-cell subsets were adopted from a previous report52 with
modifications as described in Supplementary Methods. Single cell sorting from NSG mice
was performed on early immature and immature B-cell subsets from the bone marrow (BM)
and new emigrant/transitional and mature B-cell subsets (both CD5− and CD5+) from the
peripheral blood (PB).
Single cell RT-PCR and analysis of Ig heavy and light chain gene segments
RT-PCR reactions were performed as described earlier (Supplementary Methods).18, 52
Expression and purification of scFvFc
Cognate variable heavy and light chain gene segments amplified from single B-cells were
assembled following cloning into a human IgG1-Fc expressing vector, transiently
transfected in 293FT cells (Invitrogen). The expressed single chain antibody fragments
(scFvFc) were purified as described in Supplementary Methods.
Detection of self (auto)-reactive and polyspecific antibodies
QUANTA Lite™ ANA (anti-nuclear antibody) ELISA (INOVA Diagnostics, San Diego,
CA) was used to test self-reactivity of the antibodies. 4E10 scFvFc and sera from patients
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controls in this assay. Purified antibodies were tested at 50 μg/ml, and reactive samples were
further confirmed at 25 μg/ml. The cutoff at OD450 for positive reactivity was calculated at
≥80% of the absorbance reading obtained for the manufacturer provided low positive
control.
The electrochemiluminescent (ECL) based MSD platform (Meso Scale Discovery,
Gaithersburg, MD) was used to evaluate the auto- and polyreactivity of hNSG-derived
scFvFcs. Human single- and double stranded DNA (ssDNA and dsDNA), recombinant
insulin, cardiolipin, lipopolysaccharide (LPS, Sigma, St. Louis, MO) at 10 μg/ml and
recombinant HIV-1 gp140-trimer from YU2 strain38 at 5 μg/ml were used as polyreactive
antigens in this assay. Each well in MSD 384-well High Bind MULTI-ARRAY® plates was
coated with 5 μl of polyreactive antigens in PBS (cardiolipin in 20% alcohol) at 4°C
overnight. The plates were blocked with 35 μl of 10% FBS/PBS for 1 h with shaking at 800
rpm on the microplate shaker. After washing with 35 μl PBST, purified scFvFcs were added
at 5 μg/ml, and the plates were incubated at room temperature for 2 h with shaking. 4E10
scFvFc was used as a positive control. Goat anti-human IgG-Fc Ab with SULFO-Tag (15 μl
at 1 μg/ml in 1% FBS/PBS) was used as the detection antibody, and the plates were read on
the MSD Sector Imager 2400 according to the manufacturer’s protocol. Routine ELISA
(Supplementary Methods) was also performed to analyze auto/polyreactivity in hNSG and
normal human serum samples. 4E10 IgG (NIH, AIDS Research and Reference Reagent
Program) was used as a positive control to estimate the level of autoreactivity.
Affinity measurements by Biolayer Interferometry (BLI)
Kinetic analysis of the hNSG-derived scFvFcs, b12-IgG and 4E10 IgG was performed by
measuring binding affinity to recombinant HIVgp140 trimeric protein. Analysis was
performed by BLI using the Octet Red instrument (Forte Bio, Menlo Park, CA)
(Supplementary Methods).
Statistical analysis
To analyze differences in distribution of various gene segments across different B-cell
subsets, non-parametric statistical methods were used since the data were not normally
distributed. Differences were assessed for statistical significance by the Fisher-Freeman-
Halton test. Monte Carlo estimation (10 000 samples) was used to approximate the exact
tests. Significant differences in the H-CDR3 length and N1 and N2 insertion across B-cell
subsets were determined by fitting one-way analysis of variance using SAS PROC GLM
(SAS, Cary, NC). Differences in the utilization of individual gene segments were analyzed
by one sample binomial test. Differences in utilization of particular gene segments between
mature and immature B-cell subsets were analyzed by using a two-sample test for equality
of proportions with continuity correction. Mann-Whitney U tests (two-tailed) (Graph Pad,
La Jolla, CA) were performed to determine statistically significant differences between
median values of each ELISA data set. P values < 0.005 were considered significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1.
Sorting criteria of human B cell subsets from humanized NOD/SCID γcnull (hNSG) mice.
(a) Single cell suspension was prepared from the bone marrow of a representative single
hNSG mouse and cells in the lymphoid gate (not shown) were further gated for CD19+CD5−
expression (left). Cells were then plotted for surface IgM (sIgM) and CD10 expression
(right), and single B cells from the early immature (sIgM− CD10+) and immature
(sIgM+CD10+) subsets were sorted. (b) PBMCs were prepared from 3 hNSG mice, all
transplanted with the same donor and were gated for lymphoid population (not shown).
These lymphocytes were gated on IgM+ cells (middle left) and further characterized as
CD19+CD5− or CD19+CD5+. Sorting was performed in the CD19+CD5− gate to obtain
single B cells from the new emigrant (CD10+CD27−) and mature (CD10+CD27−) B cell
subsets (lower left). Similarly the CD5+CD19+ gated cells were single sorted to obtain CD5+
mature B cells (CD10+CD27−) (lower right). Single cell sortings were performed between
8–10 months post engraftment of the hNSG mice. All antibodies used were specific for
human cell surface markers.
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Analysis of the human immunoglobulin VH repertoire in hNSG mice. The frequency of
utilization of the different VH gene families (upper panel), DH (middle) and JH (lower) gene
families across the different B cell subpopulations (indicated above pie charts) is shown.
The number in the center of each pie chart indicates the total sample size for the particular B
cell subset. Any significant difference in the overall usage of specific gene families in each
B cell populations was assessed by Fisher’s test. Usage of VH3 family was significantly
higher in all cell subsets (p<0.005) except the new emigrant B cells. Sequence identities and
categorizations into different VH gene families were performed using the IMGT database.
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Composition of the third complementarity region in the human immunoglobulin heavy chain
(H-CDR3) regions. (a) The pie charts indicate length (amino acid residues) (upper panel),
total positive charge content (middle) and percentage composition of total Y and G residues
in each H-CDR3 region analyzed (lower). The different B-cell subpopulations from which
the samples were derived are indicated above each pie chart. The number in the center of
each pie chart indicates the total sample size for the particular B cell subset. (b) Average N-
nucleotide insertions and JH exonuclease activity across the different B cell subsets are
listed. All analyses were performed using the IMGT database.
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Analysis of the Vκ repertoire and VH- Vκ pairing in human B cells from hNSG mice. (a)
The frequency of utilization of the different Vκ (upper panel) and Jκ (lower) gene families
across the different B cell subpopulations as indicated above each pie chart is shown. The
number in the center of each pie chart indicates the total sample size for the particular B cell
subset. (b) VH-Vk pairs were classified into two groups – VH/non Vκ4-1 pairings and VH/
Vκ4-1 pairings, their percentages over total number of VH-Vk pairing in a particular B cell
subset were calculated and plotted as shown. A significant decrease in the incidence of VH/
Vκ4-1 pairings (or conversely, an increase in VH/non Vκ4-1 pairings) was observed in the
mature B cell subsets (CD5− and CD5+ subsets, combined) in comparison to the bone
marrow derived B cell (early immature and immature subsets, combined) (Fisher’s Test,
p<0.005).
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Polyreactivity in the sera of hNSG mice. Sera from 5 hNSG mice at 10 months post
engraftment and 5 normal human subjects were tested by ELISA for binding to different
antigens as listed above each graph. Antigens were coated on 96 well plates, and each serum
sample was tested in two sets of duplicates, each set scored for human IgM or IgG (x-axis)
mediated antigen binding using the appropriate detection antibody, i.e. anti-human IgM and
anti-human IgG, respectively both conjugated to HRP. All serum samples were used at
1:100 dilution. Total human IgM and IgG content were 10–50 and 100–200 fold higher
respectively, in the human sera compared to the hNSG sera. Sera from unengrafted hNSG
mice showed no reactivity (not shown). Each dot represents an individual hNSG mouse or
human subject as indicated on the x-axis, and a scatter plot along with the mean for each
group is shown. The horizontal dashed line represent the level of reactivity by 4E10 IgG (5
μg/ml) used as a positive control. Significant differences in reactivity between data sets as
indicated (*p<0.005) were calculated using the Mann-Whitney unpaired t-test.
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Auto and polyreactivity analysis of the hNSG derived scFvFcs. (a) Hep-2 ELISA was
performed with scFvFcs assembled and expressed from each B cell subset and that were
purified from 293FT cell culture supernatants by Protein A chromatography. ELISA was
performed using commercially available QUANTA Lite™ ANA ELISA plates. The assay
was performed twice once with 50 μg/ml and repeated with 25 μg/ml of the scFvFcs. The
horizontal dashed line represents the low positive control (manufacturer provided) cut-off
and the numbers below each scatter plot represent the total number and percentage of the
scFvFcs those were scored as reactive in the Hep-2 assay. Each dot represents a single
scFvFcs, and the horizontal bar represents mean reactivity for each cell subset. A single
scFvFc determined to be polyreactive (see Figure 6b) in each B cell subset has been color
coded (red dot) for correlation between autoreactivity and polyspecificity. Autoreactivity
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twas significantly higher in the mature B cell (median reactivity in Mature vs. Early
immature/Immature/New emigrant and Mature CD5+ vs. Early immature/Immature/New
emigrant, p<0.005). (b) Polyreactivity of the scFvFcs isolated from the different B cell
subsets (indicated on the x-axis) was tested using the MSD platform. 384-well plates were
coated with the different antigens as listed above each plot. scFvFcs were tested at a
concentration of 5 μg/ml, and all samples were tested in duplicates. The mean value in MSD
raw numbers (y-axis) as obtained in the MSD Sector Imager was plotted. 4E10 scFvFc was
used as positive control represented as the horizontal dashed line in each plot and readings
obtained with PBS binding to antigen coated wells was considered as background. Each dot
represents the binding of individual scFvFcs, and the horizontal bar represents mean
reactivity for each cell subset. A single scFvFc in each B cell subset was color coded (red
dot) for correlation of polyspecificity across different antigens. Polyspecificity was
significantly higher in the mature B cell subsets (median reactivity in Mature vs. Early
immature/Immature/New emigrant and Mature CD5+ vs. Early immature/Immature/New
emigrant, p<0.005). Differences in median reactivity between the scFvFcs of each B cell
subset were calculated using the Mann-Whitney unpaired t-test.
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Binding of hNSG Abs to recombinant HIV-1gp140. (a) Sera from 5 hNSG mice and 5
normal human subjects were tested by ELISA for binding to recombinant HIV-1gp140
coated at a concentration of 5 μg/ml per well. Each serum sample was tested in two sets of
duplicates, each set scored for human IgM or IgG (x-axis) mediated antigen as described
previously (see Figure 5). All serum samples were used at 1:100 dilution. The horizontal
dashed line represent the level of reactivity by 4E10 IgG (5 μg/ml) used as a positive
control. Significant differences in reactivity between data sets as indicated (*p<0.005) was
calculated using the Mann-Whitney unpaired t-test. (b) HIV-1gp140 reactivity of the
scFvFcs isolated from the different B cell subsets (indicated on the x-axis) was tested using
the MSD platform. HIV envelope protein was coated at a concentration of 5 μg/ml per well.
All samples were tested in duplicates, and the mean value in MSD raw numbers (y-axis) as
obtained in the MSD Sector Imager was plotted. 4E10 scFvFc was used as positive control
(represented as the horizontal dashed line), and readings obtained with PBS binding to
antigen coated wells was considered as background. Each dot represents the binding of an
individual scFvFcs, and the horizontal bar represents mean reactivity for each cell subset.
The same scFvFcs in each B cell subset has been color coded (red dot) as in Figure 6.
Reactivity to HIV-1gp140 was significantly higher in the mature B cell subsets (median
reactivity in Mature vs. Early immature/Immature/New emigrant and Mature CD5+ vs. Early
immature/Immature/New emigrant, p<0.005). Differences in median reactivity between the
scFvFcs of each B cell subset were calculated using the Mann-Whitney unpaired t-test. (c)
Affinity measurements of the hNSG derived scFvFcs to HIV-1gp140 were obtained using
Biolayer interferometry. Representative sensorgrams of two HIV BnABs (b12-IgG and
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t4E10-IgG) and two randomly selected polyreactive scFvFcs (NM10-1 and N1M10-1, color
coded in Figure 6) binding to different concentrations of recombinant HIVgp140 trimer are
shown. Antibodies were loaded on Protein A sensors which were dipped into recombinant
HIVgp140 in solution to determine association followed by dissociation in PBS. Traces
were obtained for antibody binding to a range of HIVgp140 trimer concentrations.
Dissociation was performed for up to 1800 s, but steady state was attained by 600 s which is
shown here. Binding responses to <10 nM HIV envelope protein were negative in case of
the scFvFcs; therefore only the binding traces obtained for 50 nM and 16.6 nM and 5.6 nM
of HIVgp140 are shown. Experiments were repeated at least three times with different lots
of proteins. Affinity measurement values for each antibody are described in Results.
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Table 3
Potential VH replacement analysis of the human IG sequences from various B cell subsets1
1
Nucleotide sequence nomenclature used in the table is from IMGT. The listed sequences start from the first nucleotide of the cryptic
recombination signal sequence (indicated in upper case), through the V-D junction into the DH region. The VH donor family, DH family, JH
family and Replacement (Recipient) family (R Fam) designations are listed as well. The bold and underlined nucleotides and amino acids in the V-
D (N1) region match the 3′-end of the VH germline of the replacement family and the charged amino acids are shown in red. VH replacement
sequences represent 5% of the total number of Abs analyzed. Italics in the VH donor column represent gene segments that are downstream to the
recipient and thus correspond to a potential non-conventional VH replacement process.
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